Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
alexion pharmaceuticals
ally bridge group
amyotrophic lateral sclerosis (als)
autoimmune disorders
big data analytics
blackrock
casdin capital
complement system
deals
diabetic nephropathy
eventide asset management
fda
focal segmental glomerulosclerosis
generalized myasthenia gravis
goldfinch bio
immune-mediated necrotizing myopathy
irving investors
jay ghosh
national top stories
ra pharmaceuticals
rare disease drugs
schroeder adveq
software
third rock ventures
ucb
wellington management company
yonjin capital
zilucoplan
What
drug
lead
2
×
medicines
2
×
alternative
analysis
autoimmune
bio
biotech
bring
candidate
company
deal
develop
disease
diseases
employing
expensive
genetic
goldfinch
ipo
kidney
later
million
new
pharma
pharmaceuticals
potential
ra
raised
raises
stakes
studies
territory
ucb
viewed
world
Language
unset
Current search:
lead
×
boston
×
medicines
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma